8 result(s) displayed (1 - 8 of 8):

Cleantech deals offer ray of economic hope (from Corporate Dealmaker)

After a recent falloff, it looks like the cleantech sector is showing signs of a turnaround. The Cleantech Group, a provider of global market research, events and advisory services for the cleantech sector, along with Deloitte, released preliminary second-quarter results for clean technology venture investments in North America, Europe, China...

Posted on July 1, 2009 3:05 PM

Intel Capital ups China fund (from Corporate Dealmaker)

Intel Capital continues to aggressively invest outside the U.S. under the direction of president Arvind Sodhani. As Olaf de Senerpont Domis reports over at our sister blog Tech...

Posted on April 8, 2008 2:27 PM

Emerging markets watch: Resource roundup for India, China (from Corporate Dealmaker)

If you're a corporate dealmaker pursuing growth strategies in China or India, there's a wealth of resources out there. But whether they're surveys or reports from consultants, presentations at conferences around the world or reports from news organizations, the trick is finding and making sense of them. That's the purpose...

Posted on March 13, 2008 7:38 AM

Emerging markets watch: India's new budget and its impact on foreign investors (from Corporate Dealmaker)

India's latest budget, presented in New Delhi on Feb. 29 by Finance Minister Palaniappam Chidambaram, has already drawn plenty of commentary on what it means for various constituencies, and for the prospects of the ruling Congress party in the next election.Here at Corporate Dealmaker, we're particularly interested in the question of...

Posted on March 3, 2008 8:17 AM

Blurring the boundaries (from Corporate Dealmaker)

In China's developing dealscape, private equity, venture capital and strategic investors all compete - and cooperate - in ways not seen elsewhere.

Posted on August 15, 2007 7:41 PM

Nonprofit? Not exactly (from Corporate Dealmaker)

Kaiser Permanente's Chris Grant looks for strategic benefits from healthcare venture investments, but ROI counts too.

Posted on June 15, 2006 8:41 PM

They're alive! (from Corporate Dealmaker)

Hatching startups based on internal R&D isn't easy, but companies such as British Telecom are managing to do it.

Posted on June 15, 2005 8:10 PM

Lilly's prescription for growth (from Corporate Dealmaker)

Eli Lilly and Co. spent $2.4 billion on life-science R&D last year, exploring everything from antisense technology to synthetic exendin-4. But the biggest experiment under way at the company isn't taking place in a lab or a clinic. And the results of that experiment - highly promising so far...

Posted on August 15, 2004 5:45 PM